Bloomage Biotechnology Corp Ltd
SSE:688363

Watchlist Manager
Bloomage Biotechnology Corp Ltd Logo
Bloomage Biotechnology Corp Ltd
SSE:688363
Watchlist
Price: 54 CNY -2.32% Market Closed
Market Cap: 26B CNY
Have any thoughts about
Bloomage Biotechnology Corp Ltd?
Write Note

Relative Value

The Relative Value of one Bloomage Biotechnology Corp Ltd stock under the Base Case scenario is 93.03 CNY. Compared to the current market price of 54 CNY, Bloomage Biotechnology Corp Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
93.03 CNY
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
64
Median 3Y
7.1
Median 5Y
11.3
Industry
7.6
Forward
4.1
vs History
61
vs Industry
4
Median 3Y
59.9
Median 5Y
69.4
Industry
22.1
Forward
36.7
vs History
87
vs Industry
6
Median 3Y
58.2
Median 5Y
73.8
Industry
21.9
vs History
vs Industry
0
Median 3Y
-73.6
Median 5Y
-98.9
Industry
23.4
vs History
88
vs Industry
21
Median 3Y
6.7
Median 5Y
9.6
Industry
2.5
vs History
87
vs Industry
55
Median 3Y
6.9
Median 5Y
11
Industry
7.5
Forward
4.1
vs History
87
vs Industry
48
Median 3Y
9.3
Median 5Y
14.3
Industry
9.3
vs History
64
vs Industry
3
Median 3Y
51.5
Median 5Y
59.2
Industry
4.2
Forward
25.8
vs History
64
vs Industry
3
Median 3Y
51.5
Median 5Y
59.2
Industry
4
Forward
37.6
vs History
85
vs Industry
5
Median 3Y
56.3
Median 5Y
72.3
Industry
5.9
vs History
vs Industry
0
Median 3Y
-168.9
Median 5Y
-238.8
Industry
3.9
vs History
93
vs Industry
33
Median 3Y
6.6
Median 5Y
13.1
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Bloomage Biotechnology Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
26B CNY 4.5 59.1 48.3 48.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.2B USD 5.6 61 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
142B USD 4.4 33.4 16.1 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD 4.1 910 10.1 10.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD 9.5 -211.2 20.8 21.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD 5.6 16.8 15.3 17
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.6 -109.5 -79.8
P/S Multiple
Revenue Growth P/S to Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average P/S: 3 457 240.3
4.5
39%
0.1
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average P/E: 185.3
59.1
85%
0.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
910
77%
11.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -211.2
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average EV/EBITDA: 20.8
48.3
107%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16.1
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.8
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average EV/EBIT: 25.1
48.3
57%
0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top